Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-03-22FDA Approved: ROFLUMILAST — Original Application (Micro Labs Limited)
FDA approves Micro Labs Limited's generic roflumilast (original ANDA) for chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort [Phase 4]
Phase 4 trial updating outcomes after switching symptomatic COPD patients from salmeterol/fluticasone to indacaterol/glycopyrronium.
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Absorption & Elimination of Radiolabelled GSK2269557 [Phase 1]
Phase 1 trial update on absorption and elimination of radiolabeled GSK2269557; results completed and posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD [Phase 3]
Phase 3 trial assessing PT003 and placebo on airway volumes and resistance in moderate-to-severe COPD; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen [Phase 4]
Phase 4 trial evaluating a fixed-dose combination of glycopyrronium and indacaterol/glycopyrronium bromide for COPD patients switching from …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers [NA]
A completed COPD trial comparing nebulizers to dry powder inhalers; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Evaluating Forced Oscillation Technique (FOT) in Abolishing Flow Limitation [NA]
A completed clinical trial evaluating the Forced Oscillation Technique for addressing flow limitation in chronic obstructive pulmonary disea…
-
FDA approval · 2019-03-15FDA Approved: ALBUTEROL — Original Application (Nivagen Pharmaceuticals Inc)
FDA approves the original ANDA for albuterol sulfate (albuterol) from Nivagen Pharmaceuticals Inc, making a generic albuterol product availa…
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Venovenous CO2 Removal (VVCO2R) in Patients With COPD and Acute Respiratory Failure [NA]
Clinical trial update for venovenous CO2 removal in COPD patients with acute respiratory failure; study terminated with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospitalized With COPD Exacerbations
A clinical trial evaluating vagus nerve stimulation for managing bronchoconstriction in COPD exacerbations was terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Improving Patient-Centered Care Delivery Among Patients With Chronic Obstructive Pulmonary Disease [NA]
Clinical trial update on improving patient-centered care delivery for chronic obstructive pulmonary disease; study completed with results po…
-
FDA approval · 2019-02-25FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's Albuterol Sulfate HFA inhalation product, authorizing changes under the approved NDA/appr…
-
CLINICAL_TRIALS research · 2019-02-22Clinical Trial Update: Chest Wall Motion Analysis in Disease
This completed clinical trial examines chest wall motion analysis across several diseases, including mesothelioma, lung cancer, COPD, cystic…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Optimization of Pulmonary Rehabilitation Programmes: the OPTION Study [NA]
The OPTION study, examining optimization of pulmonary rehabilitation for COPD, has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Oral β-Alanine Supplementation in Patients With COPD [NA]
A clinical trial studying oral beta-alanine supplementation in chronic obstructive pulmonary disease has completed.
-
FDA approval · 2019-02-21FDA Approved: PREDNISONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for prednisone from Mylan Pharmaceuticals, indicating approval of an existing generic product's …
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD [Phase 3]
Phase 3 study evaluating the efficacy and safety of PT003, PT005, and PT001 in moderate to very severe chronic obstructive pulmonary disease…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Interest of Branched Chain Amino Acids Associated With a Respiratory Rehabilitation Program in Patients Broncho Chronic Obstructive Pulmonary Disease [NA]
A completed clinical trial evaluated the use of branched-chain amino acids in combination with a respiratory rehabilitation program for pati…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Randomized Controlled Study to Investigate the Impact of Different Intensities Training on ADL and BODE Index in COPD [NA]
A randomized controlled trial assessed how different exercise intensities affect activities of daily living and the BODE index in chronic ob…
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Physiological and Clinical Changes in NHF Therapy [NA]
This completed trial reports physiological and clinical changes observed with nasal high-flow therapy in patients with chronic obstructive p…
-
CLINICAL_TRIALS withdrawal · 2019-02-18Clinical Trial Update: Discovery of the Impact of Targeted Lung Denervation (TLD) on the Severe and Very Severe COPD Population
A clinical trial assessing the impact of Targeted Lung Denervation for severe to very severe COPD has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of multiple ascending doses of AZD8871 in healthy subjects; results post…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Mechanisms and Impact of Bacterial Colonisation in COPD [NA]
A completed clinical trial investigating the mechanisms and impact of bacterial colonisation in chronic obstructive pulmonary disease (COPD)…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: PATient Navigator to rEduce Readmissions [NA]
A clinical trial update for a patient navigator aimed at reducing hospital readmissions, with completed status and results posted in 2019, i…
-
FDA approval · 2019-02-14FDA Approved: SPIRIVA RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Spiriva Respimat tiotropium inhalation spray from Boehringer Ingelheim Pharmaceuticals.